ask="N/A"
ask_size="N/A"
average_daily_volume="375402"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="N/A"
change_from_200_day_moving_average="-3.95"
change_from_50_day_moving_average="-1.20"
change_from_52_week_high="-14.86"
change_From_52_week_low="18.08"
change_in_percent="N/A"
close="46.12"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="23962000"
high="N/A"
high_52_weeks="60.98"
last_trade_date="2/13/2017"
last_trade_price="46.12"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="28.04"
market_capitalization="1.25B"
moving_average_200_day="50.07"
moving_average_50_day="47.32"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="N/A"
pe_ratio="5.15"
peg_ratio="0.34"
percent_change_from_200_day_moving_average="-7.90%"
percent_change_from_50_day_moving_average="-2.53%"
percent_change_from_52_week_high="-24.37%"
percent_change_from_52_week_low="+64.48%"
previous_close="46.12"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.10"
price_per_sales="3.24"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="0"
weeks_range_52="28.04 - 60.98"
